CDXS:NASDAQ
Codexis Inc
$2.60
arrow_upward
+1.76%(+0.045) 1D
$2.65
arrow_upward
+1.73% (+0.045)todayPre-market
Closed: Jun 8, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CDXS...
Open
$2.62
High
$2.68
Low
$2.60
Mkt. cap
236.79M
Avg. vol.
1.09M
Volume
301.00
52-wk high
$3.87
52-wk low
$0.96
EPS
-$0.36
Beta
2.48
Shares outstanding
90.90M
No. of employees
146
Open
$2.62
High
$2.68
Low
$2.60
Mkt. cap
236.79M
Avg. vol.
1.09M
Volume
301.00
52-wk high
$3.87
52-wk low
$0.96
EPS
-$0.36
Beta
2.48
Shares outstanding
90.90M
No. of employees
146
Analyst outlook
Analyst Ratings
Based on 5 analysts giving stock ratings to CDXS in the past 3 months
Strong Buy
Buy
4
Hold
1
Sell
0
12 month forecast
Based on 5 Wall Street analysts offering 12 month price targets for CDXS in the last 3 months.
Highest
Current $2.60
$11.00 (+322.26%)
Average
$6.90 (+164.88%)
Lowest
$2.00 (-23.22%)
News stories
From sources across the web
Axios
·
28 minutes ago
AI use is behind a boom in solo founders, Nasdaq finds
Yahoo Finance
·
51 minutes ago
Here's Why We're A Bit Worried About Voyager Therapeutics' (NASDAQ:VYGR) Cash Burn Situation
TradingView
·
27 minutes ago
Dow futures climb 125 points: 5 things to know before Wall Street opens
MarketWatch
·
17 hours ago
BofA sees ‘red flags’ in the U.S. stock market. Here’s what to buy now.
Profile
Codexis, Inc. is a protein engineering company that develops enzymes for pharmaceutical, food and medical applications. Wikipedia
About Codexis Inc
CEOJohn Nicols
Employees146
Founded2002
HeadquartersRedwood City, California, United States
SectorHealth care
Websitecodexis.com
AI content may include mistakes. Learn more